• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Cell size and cell-cycle states play key decision-making role in HIV

Bioengineer by Bioengineer
December 26, 2018
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Illinois Department of Bioengineering.


Thanks to the development of antiretroviral drugs, human immunodeficiency virus (HIV) is considered a manageable chronic disease today. However, if left undiagnosed or untreated, HIV can develop into AIDS (acquired immune deficiency syndrome), a disease which led to the deaths of nearly 1 million people worldwide in 2017.

The life-saving drugs don’t cure HIV, though, because when the virus infects the body, it insidiously targets the very cells required to trigger the body’s immune response to any infection. Specifically, HIV invades CD4 T-cells–a type of white blood cell–making copies of itself and taking over the CD4 host cell’s DNA.

“Upon infection of a CD4 T-cell, HIV undergoes one of two fates,” said University of Illinois Assistant Professor Roy Dar. “It either integrates into a replicating state, leading to the production of hundreds of infectious virions, or it integrates into a latent state where the provirus lies transcriptionally silent.”

According to Dar, researchers have focused on eradicating the latent reservoir because it can reactivate spontaneously, evade drug therapy, or be a source for viral rebound, which can occur if a patient does not strictly adhere to the antiretroviral therapy treatment regimen.

“To date, there is no way to distinguish between uninfected cells and latently infected cells in the body, but such an ability would support existing therapeutic approaches to curing HIV,” said Dar, who is affiliated with the Electrical & Computer Engineering Department and Carl Woese Institute for Genomic Biology on campus.

In a recent study, Dar and his research group investigated the reactivation of T-cells that were latently infected with HIV in the lab by using a viral construct that contained a gene for a green fluorescent protein (GFP) that gets expressed when a cell reactivates.

“The method of time-lapse, single-cell imaging allowed monitoring single latent cell reactivation from their silent to their active states by calculating the mean fluorescence of GFP,” explained Bioengineering Post-Doctoral Researcher Kathrin Bohn-Wippert, the lead author of the study.

Once they identified the cells that were reactivated, they calculated the cell size and determined the mean cell diameter necessary for reactivation. They discovered that within a latent population, only larger host cells reactivate while the smaller cells remain silent or latent.

According to Bohn-Wippert, this larger host-cell size provides a natural cellular mechanism for enhancing burst size of viral expression and is necessary to destabilize the latent state while biasing viral decision making.

“Our results present a case of passive host-cell dominated viral decision-making, in which the virus is off when the infected cell is small and can only spontaneously reactivate in larger cell sizes,” said Dar. “This presents a case of the host cell depicting the right conditions for viral decision-making to occur.”

The team also determined that the cells’ transition from latent to active is dependent on the cell cycle–the stages by which cellular DNA replicates–and can be modulated with drug treatments. “We showed that you can use drug treatments to modulate a population of cells in and out of a specific cell cycle state in order to bias their viral reactivation,” said Dar.

These findings may be useful in guiding stochastic design strategies for drug therapies, have applications in synthetic biology, and play a role in advancing HIV diagnostics and treatments.

###

The full paper, “Cell size-based decision-making of a viral gene circuit,” published in the journal Cell Reports is available online.

Other members of the research team include: Bioengineering seniors Erin Tevonian and Melina Megaridis, Bioengineering doctoral candidate Yiyang “Tony” Lu, and Bioengineering graduate student Meng-Yao Huang.

This work was funded by the National Institutes of Health and the Cancer Center at Illinois through its Cancer Scholars program.

Media Contact
Roy Dar
[email protected]
217-265-0708

Tags: AIDS/HIVCell BiologyHealth CareMedicine/HealthPublic Health
Share12Tweet7Share2ShareShareShare1

Related Posts

blank

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

August 2, 2025
blank

AI-Driven Protein Design Advances T-Cell Immunotherapy Breakthroughs

August 1, 2025

Melanthiaceae Genomes Reveal Giant Genome Evolution Secrets

August 1, 2025

“Shore Wars: New Study Tackles Oyster-Mangrove Conflicts to Boost Coastal Restoration”

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    43 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Disparities in Pancreatic Cancer Surgery Outcomes

Real-Time Deep Learning for Nonlinear System Control

Special Collection: 2024 Aging Innovation Conference

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.